A Phase 3 interventional study of Ginkgo biloba & Methylprednisolone and Ginkgo biloba in Vestibular Neuritis, sponsored by Asan Medical Center. Completed at 1 site in Korea, Republic of. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2019-01-10.
Sponsored by Asan Medical Center · Phase 3, Interventional, and Treatment
The purpose of this study was to compare the treatment effectiveness of steroid therapy for vestibular neuritis by using video head impulse test.
This study was a prospective, randomized controlled study. The enrolled vestibular neuritis patients were randomized to conservative treatment or steroid treatment when they are diagnosed with caloric test. After initial vestibular work-up including caloric, video head impulse tests, and a questinnaire (DHI), the patient was examined with the same tests again at 6 months later. The efficacy of steroid for the patients with vestibular neuritis would be determined by the comparison of the data of each group.
34 studies on the registry are indexed under Vestibular Neuronitis; 4 are open to participants now.
This study's enrollment of 40 is below the median of 50 across 27 interventional studies indexed under Vestibular Neuronitis.
Browse Vestibular Neuronitis studies →Asan Medical Center is the lead sponsor of 578 studies on the registry; 73 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients receive Ginkgo biloba \& methylprednisolone per oral.
Drug: Ginkgo biloba & Methylprednisolone
Patients receive Ginkgo biloba per oral.
Drug: Ginkgo biloba
Drug pages: Ginkgo biloba extract · Methylprednisolone
Ginkgo biloba 160 mg/day (per oral, 80 mg twice a day) for 1 month. Methylprednisolone 48 mg/day(per oral, once a day for first 9 days. And then methylprednisolone tapering was started every 2 days. The entire duration of methylprednisolone treatment was 14 days.
Also known as: Ginexin, Methylprednisolone
Ginkgo biloba 160 mg/day (per oral, 80 mg twice a day) for 1 month.
Also known as: Ginexin
The improvement in vestibular function test (caloric & videop HIT) after treatment
The effectiveness of steroid therapy was determined by comparing the improvement of vestibular function (the degree of canal paresis by caloric test; gain and presence of refixation-saccade by video HIT test).
Time frame: The first results were collected at initial diagnosis. And following results were collected 6 months after the first exam.
The improvement in dizziness handicap inventory after treatment
The effectiveness of steroid therapy was determined by comparing improvement of subjective symptoms (symptom score by DHI) in each group.
Time frame: The first results were collected at initial diagnosis. And following results were collected 6 months after the first exam.
This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Ginkgo biloba extract · Methylprednisolone